期刊文献+

心肺复苏后神经功能预后与早期平均动脉压的关系 被引量:4

The relationship between neurofunctional prognosis and early mean arterial pressure after cardiopulmonary resuscitation
原文传递
导出
摘要 目的探讨心脏骤停后综合征(post-cardiac arrest syndrome,PCAS)患者早期平均动脉压(mean arterial pressure,MAP)与出院时神经功能预后的关系。方法回顾性分析河南省人民医院2016年1月至2018年1月收治入院的PCAS病例。纳入心肺复苏后自主循环恢复(restoration of spontaneous circulation,ROSC)超过12 h的患者共151例。建立多变量logistic回归分析模型,明确0~6 h MAP与受试者预后的关联性及关联性强度;通过卡方检验明确使用血管活性药物对出院时神经功能预后的影响。结果经多变量logistic回归分析,出院时神经功能预后良好组患者的时间加权平均动脉压(TWA-MAP)显著高于预后不良组,(83.25±13.69)mmHg vs(77.06±18.37)mmHg,P=0.042;ROSC后最初的6 h内的TWA-MAP值处于71~80 mmHg(1 mmHg=0.133 kPa)组患者的良好神经功能预后率明显优于TWA-MAP小于70 mmHg的患者(11%vs 37%,P=0.009);且TWA-MAP大于70 mmHg与大于65 mmHg均是影响患者预后的独立影响因素,但TWA-MAP大于70 mmHg对神经功能预后良好的影响显著(OR=4.11,95%CI:1.34~12.66,P=0.014);在TWA-MAP达到了70 mmHg以上的患者中,未使用血管活性药物的患者良好神经功能预后率显著高于使用血管活性药物组的患者(48%vs 24%,P=0.010)。结论在PCAS的6 h内保持TWA-MAP大于70 mmHg有利于改善患者出院时神经功能预后。 Objective To discuss the relationship between neurofunctional prognosis and early mean arterial pressure(MAP)of patients with post-cardiac arrest syndrome(PCAS).Methods This retrospective study enrolled 151 PCAS patients in Henan Provincial People’s Hospital between January 2016 and January 2018.A multivariate logistic regression analysis was established to determine the correlation between the MAP at the first 6 h and the prognosis of the patients at discharge.The effect of angioactive drugs on the neurofunctional prognosis of patients at discharge was determined by chi-square test.Results The multivariate logistic regression analysis showed that the TWA-MAP of patients with good neurofunctional prognosis at discharge was significantly higher than that of patients with poor prognosis(83.25±13.69)mmHg vs(77.06±18.37)mmHg,P=0.042.In the first 6 h after ROSC,the neurofunctional prognosis of patients with good prognosis in the TWA-MAP value of 71 to 80 mmHg was significantly better than that of patients with TWA-MAP lower than 70 mmHg(11%vs 37%,P=0.009).The variable logistic regression analysis results showed that the level of TWA-MAP higher than 70 mmHg or 65 mmHg was the independent factor affecting the outcome,while the level of TWA-MAP higher than 70 mmHg had a better correlation with the neurofunctional prognosis(OR=4.11,95%CI:1.34-12.66,P=0.014).In patients with TWA-MAP higher than 70 mmHg,the neurofunctional prognosis of patients with good prognosis but without angioactive drugs was significantly better than that of those with angioactive drugs(48%vs 24%,P=0.010).Conclusion Holding TWA-MAP higher than 70 mmHg in the first 6 h after PCAS is helpful to improve the neurofunctional prognosis of patients at discharge.
作者 许丽君 崔英杰 秦历杰 Xu Lijun;Cui Yingjie;Qin Lijie(Emergency Department,Henan Provincial People’s Hospital,Zhengzhou 450003,China)
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2020年第5期711-715,共5页 Chinese Journal of Emergency Medicine
基金 河南省医学科技攻关计划(201602270)。
关键词 回顾性研究 脑损伤 心肺复苏 心脏骤停后综合征 神经功能预后 影响因素 平均动脉压 时间加权平均动脉压 Retrospective study Brain injury Cardiopulmonary resuscitation Post-cardiac arrest syndrome Neurofunctional prognosis Influencing factor Mean arterial pressure Time-weighted average mean arterial pressure
  • 相关文献

参考文献3

二级参考文献100

  • 1Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282. 被引量:1
  • 2Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005. 被引量:1
  • 3Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442. 被引量:1
  • 4Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213. 被引量:1
  • 5Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7. 被引量:1
  • 6Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312. 被引量:1
  • 7Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617. 被引量:1
  • 8Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439. 被引量:1
  • 9Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032. 被引量:1
  • 10Kwiatkowski TG, Libman RB, Fmnkel M, et al. Effects of tissue plasrrfinogen activator for acute ischemic stroke at one year. National Institute of Neurological Disordeis and Stroke Recombinxaat Tissue Plasmiogen Activator Stroke Study Group. N Engl J Med, 1999, 340: 1781-1787. 被引量:1

共引文献1035

同被引文献15

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部